IDV vehicle
36E79724D0034
NEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $11.1M |
| Start date | Oct 14, 2024 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 10, 2026 | P00003 | $0 | INCORPORATE DEI CLAUSE 52.222-90 |
| Sep 8, 2025 | P00001 | $0 | EXERCISE OPTION YEAR 1 FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2025 TO OCT 13, 2025 WITH NO PRICE CHANGES |
| Aug 15, 2024 | 0 | $0 | NEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.